Immunomodulatory Properties of Articular Chondrocytes in Joint Disease

Articular chondrocytes, long regarded primarily as matrix‐producing cells, are now recognised as active modulators of joint immunity. In healthy cartilage, they contribute to immunoprivilege by expressing low levels of major histocompatibility complex molecules and secreting anti‐inflammatory mediators such as interleukin-10, transforming growth factor-β and prostaglandin E₂. Under mechanical stress or inflammatory assault, chondrocytes upregulate pattern‐recognition receptors and cytokines including interleukin-6 and tumour necrosis factor-α, thereby shaping synovial inflammation. They also influence both innate and adaptive arms of immunity: by releasing chemokines they attract macrophages and neutrophils, while direct cell–cell interactions can suppress T-cell proliferation and inhibit monocyte differentiation into antigen-presenting cells. In osteoarthritis and rheumatoid arthritis, dysregulated chondrocyte signalling drives cartilage degradation through heightened production of matrix metalloproteinases and reactive oxygen species, exacerbating pain and loss of function. This expanded understanding of chondrocyte immunomodulation offers pathways to refine cell‐based therapies, design immunologically neutral allogeneic implants and target molecular checkpoints to restore joint homeostasis on a global scale.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Immunomodulatory Properties of Articular Chondrocytes in Joint Disease publication trend

The graph below shows the total number of articles in immunomodulatory properties of articular chondrocytes in joint disease across all publications each year (not limited to Nature Index journals).

Technical terms

Articular chondrocyte: A specialised cartilage cell in synovial joints responsible for the synthesis and maintenance of the extracellular matrix.
Immunomodulation: The alteration of immune system activity by cellular interactions or soluble mediators.
Semaphorin-3A: A guidance molecule that modulates inflammatory signalling and nerve patterning.
Neuropilin-1: A cell-surface receptor for semaphorin-3A that influences cell survival and inflammatory pathways.
Matrix metalloproteinase 13 (MMP13): An enzyme that degrades type II collagen and contributes to cartilage breakdown.
Extracellular matrix (ECM): A complex network of proteins and polysaccharides that provides structural and biochemical support to surrounding cells.

References

1. Human Articular Chondrocytes Regulate Immune Response by Affecting Directly T Cell Proliferation and Indirectly Inhibiting Monocyte Differentiation to Professional Antigen-Presenting Cells. Frontiers in Immunology (2016).
2. Semaphorin 3A-Neuropilin-1 Signaling Modulates MMP13 Expression in Human Osteoarthritic Chondrocytes. International Journal of Molecular Sciences (2022).
3. Expression of semaphorin‐3A in the joint and role in osteoarthritis. Cell Biochemistry and Function (2024).